The customizable middleware system centralizes laboratory operations and workflow across hospitals and networks, allowing blood banks and their data to be confidently managed through one central terminal.
Read More
FDA has expanded the approved use of Lynparza to include the treatment of patients with certain types of breast cancer that have spread and whose tumors have a specific inherited genetic mutation, making it the first drug in its class approved to treat breast cancer.
Read More
CancerLinQ is the American Society of Clinical Oncology’s health information technology platform, designed to leverage the power of big data to improve the quality of care for patients with cancer.
Read More
The experience of inflammatory bowel disease patients has established the positive association between therapeutic drug monitoring and improved clinical outcomes.
Read More
The study prospectively enrolled 20 stem-cell transplant patients to evaluate the Karius test for diagnosis and monitoring of infections over time.
Read More